2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Epiphany Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection Valomaciclovir, placebo - Infectious Mononucleosis | Phase 1 / Phase 2 | Completed | University of Minnesota | 23 | 2007-11-01 | 2017-03-22 |
| A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster EPB-348, Valacyclovir - Herpes Zoster | Phase 2 | Completed | Epiphany Biosciences | 373 | 2007-11-01 | 2013-12-05 |
Epstein-Barr Virus Infections (1) · Herpes Zoster (1) · Infectious Mononucleosis (1)
Valacyclovir (1) · valomaciclovir (1)
United States (2)
Henry H Balfour, MD (1) · Stephen K Tyring, MD (1)